May 31st, 2012 tmccoy
by: Michael Werner, Esq. Bisphosphonates are approved to treat osteoporosis and other bone weakening disease. The drugs, which are taken by roughly 5 million people, are sold under a variety of brand names, including: Fosamax Actonel Aredia Bonefos Boniva Didronel Reclast Skelid Zometa There have been 128 cases of bisphosphonate-associated esophageal cancer reported to the [...]
Posted in Defective Drugs, Latest News by: tmccoy
No Comments
May 31st, 2012 tmccoy
by: Stephanie Herschaft, Esq. When pregnant women take antidepressants, their babies may be more likely to be born early or have a seizure soon after birth, according to a recently published large U.S. study. SSRI antidepressants include drugs sold under the names Paxil, Prozac, Celexa, Lexapro, and Zoloft. SSRIs block the reabsorption (reuptake) of the [...]
Posted in Defective Drugs, Latest News by: tmccoy
No Comments
May 31st, 2012 tmccoy
by: Jonathan Macri, Esq. Those suffering from acne should be careful about the products they take to reduce their acne, as new research suggests they may lead to eye infections. A new study by the University of Tel Aviv’s School of Public Health has linked acne medications, such as Accutane or Roaccutane, to an increase [...]
Posted in Defective Drugs, Latest News by: tmccoy
No Comments
May 30th, 2012 tmccoy
by: Stephanie Herschaft, Esq. A J &J Unit, McNeil-PPC, is in trouble with the FDA for failing to follow up with complaints about O.B. tampons causing toxic shock syndrome and the personal lubricant K-Y Liquibeads Vaginal Moisturizer, a product which J& J never actually had permission to sell. McNeil-PPC did not tell the FDA that [...]
Posted in Defective Drugs, Latest News by: tmccoy
No Comments
May 30th, 2012 tmccoy
by: Michael Werner, Esq. Dr. Santmann recently protested outside of Merck & Co.’s New Jersey headquarters, where he explained to a crowd of supporters that his son, who recently committed suicide, “wasn’t really depressed. He was in a zombie state. He didn’t want to live in this mentally crippled state.” Dr. Santmann attributes his late [...]
Posted in Latest News by: tmccoy
No Comments
May 30th, 2012 tmccoy
by: Brett Leitner, Esq. The Centers for Medicare & Medicaid Services recently announced that they are setting a goal of reducing the use of antipsychotic drugs in nursing home residents by 15 percent by the end of this year. The federal regulators further announced that almost 40 percent of nursing home residents with signs of [...]
Posted in Latest News, Nursing Home Abuse & Neglect by: tmccoy
No Comments
May 29th, 2012 tmccoy
by: Stephanie Herschaft, Esq. The use of transvaginal mesh has proved to be more disastrous than the feminine problems, stress urinary incontinence (SUI) and pelvic organ prolapse (POP) it was supposed to repair. Women are complaining about terrible pain, bleeding and infection that they are suffering from after transvaginal mesh was implanted inside of their [...]
Posted in Defective Medical Devices, Latest News by: tmccoy
No Comments
May 29th, 2012 tmccoy
by: Michael Werner, Esq. As you may know, Parker Waichman blog articles regularly include a discussion of a drug or device’s initial U.S. Food and Drug Administration (“FDA”) approval and any subsequent scrutiny or oversight. Presently before Congress is a bill that, if passed, could reshape the FDA approval process to promote a more rigorous [...]
Posted in Defective Drugs, Defective Medical Devices, Latest News by: tmccoy
No Comments
May 25th, 2012 tmccoy
by: Stephanie Herschaft, Esq. Charles Hynes, Kings County District Attorney, will soon propose a New York State law that would require religious officials such as rabbis to report allegations of abuse to civil authorities immediately after they are notified about the allegations. Currently, many religious leaders keep allegations of sexual abuse to themselves while attempting [...]
Posted in Latest News, Personal Injury by: tmccoy
No Comments
May 25th, 2012 tmccoy
by: Michael Werner, Esq. For the second time in less than a year European regulators have asked Pradaxa manufacturer Boehringer Inglheim (“BI”) to update the drug’s label to include specific information pertaining to bleeding risks. Pradaxa—a fairly recent direct thrombin inhibitor blood thinner thought to be safer than Coumadin— was approved in Europe in March, [...]
Posted in Defective Drugs, Latest News by: tmccoy
No Comments